Navigation Links
Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women
Date:12/18/2007

ailto:journalisthelp@thenewsmarket.com">journalisthelp@thenewsmarket.com

'More Positive Conversations' global survey

The 'More Positive Conversations' survey was conducted online and via telephone interviews by Harris Interactive on behalf of AstraZeneca. The survey involved 1,062 physicians and patients from France, Germany, Italy, the United Kingdom and the US.

AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4 Good Index.

Arimidex (anastrozole) is a trademark, the property of the AstraZeneca group of companies.

References

1. The ATAC Trialist Group -Effect of anastrozole and tamoxifen as

adjuvant treatment for early-stage breast cancer; 100 month analysis of

the ATAC trial -published online, Lancet Oncology Saturday 15 December

2. Forbes J, on behalf on the ATAC Trialist's Group. ATAC: 100 month

median follow-up shows continued superior efficacy and no excess

fracture risk for anastrozole compared with tamoxifen after treatment

completion. Abstract no 41. San Antonio Breast Cancer Symposium 2007.

3. Parkin, D.M., E. Laara, and C.S. Muir, Estimates of the worldwide

frequency of sixteen major cancers in 1980. Int J Cancer, 1988. 41(2):

p. 184-97.

4. Breastcancer.org. What role to hormones play in breast cancer

treatment. Available from http://www.breastcancer
'/>"/>

SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Tapestry Reports Second Quarter 2007 Results
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... and VANCOUVER , July 30, 2015 ... today that it will report its second quarter 2015 ... will host a conference call and live webcast at ... financial results, clinical development programs and a general corporate ... on to the Investor Relations page of the OncoGenex ...
(Date:7/30/2015)... Calif. , July 30, 2015  Amgen (NASDAQ: ... , partner and managing director of Warburg Pincus LLC, to ... pleased to welcome Fred Hassan and the deep, ... Amgen Board," said Robert A. Bradway , chairman and ... commitment to innovation will serve Amgen well." Mr. ...
(Date:7/30/2015)... N.J. , July 30, 2015 Eisai ... in the United States , European ... FDA, EMA and MHLW, respectively) for eribulin, for the ... who have received prior chemotherapy for advanced or metastatic ... on data from a pivotal global Phase 3 clinical ...
Breaking Medicine Technology:Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
... CVS Caremark reiterated the company,s support that the U.S. ... approve biogeneric drugs under the Affordable Care Act. The ... Reid, testified before the FDA today during a public ... for biosimilar and interchangeable biological products held at the ...
... 2010 Spectros Corporation presented new clinical results ... Tissue Oximeter at the San Diego Convention Center ... presented during poster sessions entitled "Experimental Circulation: Ischemia ... the American Society of Anesthesiologists (ASA 2010) on ...
Cached Medicine Technology:CVS Caremark Reiterates Support for FDA Implementation of Approval Pathway for Biogeneric Drugs 2Spectros Presents New Clinical Studies Using T-Stat VLS Tissue Oximeter at Anesthesiology 2010 2
(Date:7/31/2015)... , ... July 31, 2015 , ... When the weather ... Super-Sod debuted their new type of sod called Leisure Time(TM) zoysia . It's ... process. , To commemorate introduction of this new type of sod, Super-Sod is giving ...
(Date:7/31/2015)... ... July 31, 2015 , ... Precision Aesthetics is New ... It was also the first provider of Exilis non-surgical fat reduction in New ... procedures it has attracted a large International clientele. Many patients travel to New ...
(Date:7/31/2015)... Atlanta, GA (PRWEB) , ... July 31, 2015 , ... ... CoolSculpting , the CoolSmooth PRO this week. Zeltiq Aesthetics released this new applicator ... FDA in January 2014 for treating the outer thighs. The original applicator required ...
(Date:7/31/2015)... ... July 31, 2015 , ... Coco Libre announced today ... media, and VIPs at the 2015 Vans US Open of Surfing, July 25 through ... can claim “no added sugar” on the market, is a natural choice given the ...
(Date:7/31/2015)... , ... July 31, 2015 , ... According to an ... experts gathered to see if they could reach a consensus on the steps that ... and facelifts. Overall, the group reached 90 percent consensus on a series of steps ...
Breaking Medicine News(10 mins):Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3
... ROCHESTER, Minn., Sept. 4 Should doctors be,involved ... the,September issue of Mayo Clinic Proceedings, three anesthesiologists ... this question in a commentary and,two editorials., ... is,justifiable. Instead, the authors explore the current position ...
... first public,test of voter reaction to the healthcare deal ... Fabian Nunez, California voters,are expressing serious reservations about the ... today by the California Nurses Association. More than ... percent to,25 percent -- said they prefer "making sure ...
... A University of Virginia researcher has been awarded ... Allergy and Infectious Diseases to combat a growing international ... Center for Global Health, plans to take a unique ... growing increasingly resistant to certain antibiotics that work against ...
... tips to rid homes of common allergens, OMAHA, Neb., ... our time indoors getting bombarded by contaminants and,allergens, such as ... are built so air-tight that any air that gets in ... making your housekeeping,practices all the more important. Try to ...
... ABBOTT PARK, Ill., Sept. 4 Abbott (NYSE: ... Healthcare Conference on,Tuesday, Sept. 11, 2007. Thomas C. Freyman, ... a formal presentation on the,company at 8:30 a.m. Central ... will be accessible through,Abbott,s Investor Relations Web site at ...
... Mass., Sept. 4 The National Patient Safety,Foundation ... its,Corporate Council as an Associate Member. The Corporate ... products and services companies to,work along side NPSF ... and their families with a single convergent goal,-- ...
Cached Medicine News:Health News:Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment 2Health News:Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment 3Health News:New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 8 2Health News:UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria 2Health News:Clean to Ease Allergy and Asthma Symptoms 2Health News:National Patient Safety Foundation Partners with Vocera Communications 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: